Factors affecting DNA-DNA interstrand cross-links in the antiparallel 3'-3' sense: a comparison with the 5'-5' directional isomer.
Reported herein is a study of the unusual 3'-3' 1,4-GG interstrand cross-link (IXL) formation in duplex DNA by a series of polynuclear platinum anticancer complexes. To examine the effect of possible preassociation through charge and hydrogen-bonding effects the closely related compounds [{trans-PtCl(NH(3))(2)}(2)(mu-trans-Pt(NH(3))(2){NH(2)(CH(2))(6)NH(2)}(2))](4+) (BBR3464, 1), [{trans-PtCl(NH(3))(2)}(2)(mu-NH(2)(CH(2))(6)NH(2))](2+) (BBR3005, 2), [{trans-PtCl(NH(3))(2)}(2)(mu-H(2)N(CH(2))(3)NH(2)(CH(2))(4))](3+) (BBR3571, 3) and [{trans-PtCl(NH(3))(2)}(2){mu-H(2)N(CH(2))(3)-N(COCF(3))(CH(2))(4)}](2+) (BBR3571-COCF(3), 4) were studied. Two different molecular biology approaches were used to investigate the effect of DNA template upon IXL formation in synthetic 20-base-pair duplexes. In the "hybridisation directed" method the monofunctionally adducted top strands were hybridised with their complementary 5'-end labelled strands; after 24 h the efficiency of interstrand cross-linking in the 5'-5' direction was slightly higher than in the 3'-3' direction. The second method involved "postsynthetic modification" of the intact duplex; significantly less cross-linking was observed, but again a slight preference for the 5'-5' duplex was present. 2D [(1)H, (15)N] HSQC NMR spectroscopy studies of the reaction of [(15)N]-1 with the sequence 5'-d{TATACATGTATA}(2) allowed direct comparison of the stepwise formation of the 3'-3' IXL with the previously studied 5'-5' IXL on the analogous sequence 5'-d(ATATGTACATAT)(2). Whereas the preassociation and aquation steps were similar, differences were evident at the monofunctional binding step. The reaction did not yield a single distinct 3'-3' 1,4-GG IXL, but numerous cross-linked adducts formed. Similar results were found for the reaction with the dinuclear [(15)N]-2. Molecular dynamics simulations for the 3'-3' IXLs formed by both 1 and 2 showed a highly distorted structure with evident fraying of the end base pairs and considerable widening of the minor groove.
Ruhayel
Rasha A
RA
Chemistry M313, School of Biomedical, Biomolecular & Chemical Sciences, The University of Western Australia, 35 Stirling Highway, Crawley WA 6009, Australia.
Moniodis
Joseph J
JJ
Yang
Xiaohong
X
Kasparkova
Jana
J
Brabec
Viktor
V
Berners-Price
Susan J
SJ
Farrell
Nicholas P
NP
D000970:Antineoplastic Agents / Q000737:chemistry; D001483:Base Sequence; D003198:Computer Simulation; D003432:Cross-Linking Reagents / Q000737:chemistry*; D004247:DNA / Q000737:chemistry*; D006860:Hydrogen Bonding; D007536:Isomerism; D007553:Isotope Labeling; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D009944:Organoplatinum Compounds / Q000737:chemistry
D000970:Antineoplastic Agents; D003432:Cross-Linking Reagents; D009944:Organoplatinum Compounds; D004247:DNA
Dalton Trans. 2007 Nov 21;(43):4938-42
17992278
Inorg Chem. 2001 Nov 19;40(24):6108-14
11703107
Met Ions Biol Syst. 2004;42:251-96
15206105
Lancet Oncol. 2001 Aug;2(8):483-90
11905724
J Med Chem. 2008 Apr 10;51(7):2254-60
18338842
Biochemistry. 1999 Sep 21;38(38):12305-12
10493798
J Am Chem Soc. 2004 Feb 25;126(7):2166-80
14971952
J Inorg Biochem. 2004 Oct;98(10):1585-90
15458820
FEBS J. 2006 Aug;273(15):3467-78
16824042
J Biol Inorg Chem. 2002 Apr;7(4-5):397-404
11941497
Biochemistry. 1999 May 25;38(21):6781-90
10346899
Nature. 1995 Oct 19;377(6550):649-52
7566180
Nucleic Acids Res. 1996 Dec 15;24(24):5062-3
9016685
J Mol Recognit. 1990 Feb;3(1):1-25
2191698
Electrophoresis. 1997 Dec;18(15):2714-23
9504803
Eur J Cancer. 2004 Aug;40(12):1872-7
15288289
Anticancer Drugs. 2006 Jul;17(6):697-704
16917215
Chem Rev. 2007 May;107(5):1387-407
17455916
Biochemistry. 1996 Dec 24;35(51):16705-13
8988007
Biochemistry. 2005 May 10;44(18):6764-75
15865422
Chem Rev. 2006 Feb;106(2):277-301
16464006
Front Biosci. 2004 Jan 01;9:421-37
14766379
Methods Mol Biol. 1997;90:51-79
9407527
J Biomol NMR. 1992 Nov;2(6):661-5
1490109
Chemistry. 2003 Feb 3;9(3):713-25
12569464
J Mol Biol. 2000 Jul 21;300(4):819-40
10891271
Biochemistry. 1993 Nov 2;32(43):11676-81
8218235
Biochem J. 1994 May 15;300 ( Pt 1):165-73
8198530
J Biol Chem. 2002 Dec 13;277(50):48076-86
12226099
Biochemistry. 1998 Jun 30;37(26):9230-9
9649303
Mol Pharmacol. 1999 Sep;56(3):633-43
10462551
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10394-8
7937961
J Biol Inorg Chem. 2003 Jan;8(1-2):19-28
12459895
J Am Chem Soc. 2001 Feb 21;123(7):1316-26
11456703